Actively Recruiting
Perineural Methylene Blue Infusion in Lower Limb Amputation Surgery
Led by Tanta University · Updated on 2025-07-09
72
Participants Needed
1
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This prospective randomized controlled study will be conducted to evaluate the analgesic effect of continuous perineural infusion of methylene blue with bupivacaine on acute postoperative pain and to evaluate its preventive role against chronic phantom pain in patients undergoing lower limb amputation surgery
CONDITIONS
Official Title
Perineural Methylene Blue Infusion in Lower Limb Amputation Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients of both genders
- Suffering from vascular insufficiency of one or both lower limbs
- Scheduled for above or below knee amputation under general anesthesia
You will not qualify if you...
- History of allergy to local anesthetics
- Allergy to methylene blue
- Use of anticoagulants or presence of coagulopathy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tanta University
Tanta, Gharbia Governorate, Egypt, 31527
Actively Recruiting
Research Team
O
Osama M Rehab, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here